ENTX
insider transactionsEntera Bio Ltd. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 4 different insiders made open-market purchases in the last 365 days, totalling $121.0K.
Net shares · 365d
+90.5K
90.5K buy · 0 sell
Net value · 365d
$121.0K
$121.0K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
7
90.5K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Chief Operating Officer
$0
73.0K sh
Own +81%
-
Grant·A
Chief Financial Officer
$0
58.4K sh
Own +52%
-
Grant·A
Chief of R&D
$0
87.6K sh
Own +86%
-
Buy·P
Director
$26.0K
20.0K sh · $1.30
Own +100%
-
Buy·P
Director
$12.3K
10.0K sh · $1.23
Own +6%
-
Buy·P
Director
$7.5K
5.0K sh · $1.49
Own +50%
-
Buy·P
Director
$11.1K
7.5K sh · $1.48
-
Buy·P
Director
$29.8K
20.0K sh · $1.49
-
Buy·P
Director
$12.0K
10.0K sh · $1.20
Own New
-
Buy·P
Director
$22.3K
18.0K sh · $1.24
Own +11%
-
Grant·A
Director
$0
33.5K sh
Own New
-
Grant·A
Director
$0
28.7K sh
Own +61%
-
Grant·A
Director
$0
33.5K sh
Own New
-
Grant·A
Director
$0
30.2K sh
Own +64%
-
Grant·A
Director
$0
33.5K sh
Own New
-
Grant·A
Director
$0
38.3K sh
Own +13%
-
Grant·A
Director
$0
33.5K sh
Own New
-
Grant·A
Director
$0
26.3K sh
Own +41%
-
Grant·A
Director
$0
33.5K sh
Own New
-
Grant·A
Director
$0
25.4K sh
Own +19%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 7, 2026 | Hillel Galitzer | Grant A | 73.0K | $0 |
| May 7, 2026 | Dana Yaacov-Garbeli KEY | Grant A | 58.4K | $0 |
| May 7, 2026 | Gregory Burshtein | Grant A | 87.6K | $0 |
| Mar 9, 2026 | Geno J Germano | Buy P | 20.0K | $26.0K |
| Mar 5, 2026 | Sean Ellis | Buy P | 10.0K | $12.3K |
| Feb 12, 2026 | Steven D Rubin | Buy P | 5.0K | $7.5K |
| Feb 10, 2026 | Haya Taitel | Buy P | 7.5K | $11.1K |
| Feb 10, 2026 | Geno J Germano | Buy P | 20.0K | $29.8K |
| Feb 9, 2026 | Steven D Rubin | Buy P | 10.0K | $12.0K |
| Feb 9, 2026 | Sean Ellis | Buy P | 18.0K | $22.3K |
| Jan 1, 2026 | Gerald M Ostrov | Grant A | 33.5K | $0 |
| Jan 1, 2026 | Gerald M Ostrov | Grant A | 28.7K | $0 |
| Jan 1, 2026 | Yonatan Malca | Grant A | 33.5K | $0 |
| Jan 1, 2026 | Yonatan Malca | Grant A | 30.2K | $0 |
| Jan 1, 2026 | Gerald M Lieberman | Grant A | 33.5K | $0 |
| Jan 1, 2026 | Gerald M Lieberman | Grant A | 38.3K | $0 |
| Jan 1, 2026 | Haya Taitel | Grant A | 33.5K | $0 |
| Jan 1, 2026 | Haya Taitel | Grant A | 26.3K | $0 |
| Jan 1, 2026 | Sean Ellis | Grant A | 33.5K | $0 |
| Jan 1, 2026 | Sean Ellis | Grant A | 25.4K | $0 |
About ENTX insider trading
This page tracks insider transactions for Entera Bio Ltd. (ENTX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.